Literature DB >> 3919784

Determination of maximal bactericidal activity in human granulocytes.

H Hülsheger, W Stangel, J Schmidt, J Potel.   

Abstract

A conventional in vitro test assay was used to determine maximal bactericidal capabilities of human granulocytes. By means of a mathematical model the maximal phagocytosis and killing activity could be calculated for S. aureus and P. aeruginosa serving as test organisms. The evaluation allowed moreover the determination of the optimal bacterial load and also of critical bacterial concentrations leading to a complete depression of observable granulocyte killing functions. In contrast to other studies frozen suspensions of bacteria were used allowing the employment of identical microorganisms within a complete series of experiments. On average one granulocyte was found to ingest a maximum of 17 CFU of S. aureus with 9 CFU killed under optimal ratios of bacteria per granulocyte. For P. aeruginosa the granulocyte function reached peak values of 96 CFU ingested and 62 CFU killed per one granulocyte. The new assay might provide a highly reproducible method for clinical assessment of granulocyte dysfunctions in various diseases.

Entities:  

Mesh:

Year:  1985        PMID: 3919784     DOI: 10.1007/bf00320073

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  12 in total

1.  Quantitation of maximal bactericidal capability in human neutrophils.

Authors:  C C Clawson; J E Repine
Journal:  J Lab Clin Med       Date:  1976-08

2.  Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; I Dubbeldeman-Rempt; R van Furth
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

3.  Activation of the bactericidal capacity of blood granulocytes. Evaluation of a new method and the effect of levamisole.

Authors:  J Palmblad; L Engstedt
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-12

4.  Activation of the bactericidal capacity of polymorphonuclear granulocytes after surgery, measured with a new in vitro assay.

Authors:  J Palmblad
Journal:  Scand J Haematol       Date:  1979-07

5.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

6.  The Chediak-Higashi syndrome: quantitation of a deficiency in maximal bactericidal capacity.

Authors:  C C Clawson; J E Repine; J G White
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

7.  Quantitative measurement of the bactericidal capability of neutrophils from patients and carriers of chronic granulomatous disease.

Authors:  J E Repine; C C Clawson
Journal:  J Lab Clin Med       Date:  1977-09

8.  Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.

Authors:  H A Verbrugh; R Peters; P K Peterson; J Verhoef
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

9.  Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics.

Authors:  J E Repine; C C Clawson; F C Goetz
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.